Genentech Inc 2022-11-09 Health moderate FDA
Health · FDA · Recall #FDA-D-0025-2023
Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One… Recall
Issued November 9, 2022 · Genentech Inc
In November 2022, Genentech Inc recalled the Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One…, a moderate health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.
What you should do
- 1 Stop using Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Genentech Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Genentech Inc
- Category
- Health
- Recall date
- November 9, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0025-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Genentech Inc has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.